Description
A second-generation retinoid previously used systemically to manage psoriasis but withdrawn due to teratogenicity; alters cAMP signaling, which may be defective in psoriasis
Formal name: (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic acid, ethyl ester
Synonyms: Ro 10-9359|Tegison
Molecular weight: 354.5
CAS: 54350-48-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cell Biology|Cell Signaling|cAMP Signaling